RapidAI receives FDA clearance for Rapid RV/LV

By AuntMinnie.com staff writers

February 24, 2023 -- Artificial intelligence (AI) software developer RapidAI has secured U.S. Food and Drug Administration (FDA) 510(k) clearance for its Rapid RV/LV software.

Available as part of the firm's Rapid PE detection and analysis software for suspected cases of pulmonary embolism (PE), the RV/LV software automatically calculates an important indicator of PE severity -- the ratio between the right and left ventricles -- on CT pulmonary angiograms, RapidAI said. Results are available within minutes, enabling care teams to more quickly prioritize patients and speed up decision-making, according to the vendor.

Copyright © 2023 AuntMinnie.com

To read this and get access to all of the exclusive content on AuntMinnie.com create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a AuntMinnie.com password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking